Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3404)
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
116,671
Price
$3.56
Total Value
$415.35K
Shares Held After
7,030,000
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$23.00
Total Value
$115.00K
Shares Held After
401,288
% of Holdings
1.2%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
152,472
Price
$8.93
Total Value
$1.36M
Shares Held After
16,970,045
% of Holdings
0.9%
CRESCENT BIOPHARMA, INC. (CBIO)
Fairmount Funds Management LLC — Director
Shares
853,450
Price
$14.50
Total Value
$12.38M
Shares Held After
3,601,316
% of Holdings
23.7%
INCYTE CORP (INCY)
Issa Mohamed Khairie — EVP, Head of U.S. Commercial
Shares
1,093
Price
$115.01
Total Value
$125.71K
Shares Held After
63,940
% of Holdings
1.7%
INCYTE CORP (INCY)
Stein Steven H — CMO&Head of Late-Stage Dev.
Shares
1,877
Price
$114.73
Total Value
$215.35K
Shares Held After
21,118
% of Holdings
8.2%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
1,592
Price
$37.44
Total Value
$59.60K
Shares Held After
192,079
% of Holdings
0.8%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
7,464
Price
$36.66
Total Value
$273.63K
Shares Held After
193,671
% of Holdings
3.7%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
1,476
Price
$37.44
Total Value
$55.26K
Shares Held After
162,709
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
6,979
Price
$36.66
Total Value
$255.85K
Shares Held After
164,185
% of Holdings
4.1%
Lyell Immunopharma, Inc. (LYEL)
Innovative Cellular Therapeutics Holdings Ltd — 10% Owner
Shares
10
Price
$13.73
Total Value
$137.30
Shares Held After
2,857,490
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
92
Price
$37.96
Total Value
$3.49K
Shares Held After
1,263,234
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
28,091
Price
$37.26
Total Value
$1.05M
Shares Held After
1,263,326
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
40,899
Price
$36.46
Total Value
$1.49M
Shares Held After
1,291,417
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
12
Price
$37.96
Total Value
$455.52
Shares Held After
226,539
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
3,526
Price
$37.26
Total Value
$131.38K
Shares Held After
226,551
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,009
Price
$36.45
Total Value
$182.58K
Shares Held After
230,077
% of Holdings
2.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
19
Price
$37.96
Total Value
$721.24
Shares Held After
302,557
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
5,865
Price
$37.26
Total Value
$218.53K
Shares Held After
302,576
% of Holdings
1.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,163
Price
$36.46
Total Value
$334.08K
Shares Held After
308,441
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
11
Price
$37.96
Total Value
$417.56
Shares Held After
146,953
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
3,331
Price
$37.26
Total Value
$124.11K
Shares Held After
146,964
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
4,776
Price
$36.45
Total Value
$174.09K
Shares Held After
150,295
% of Holdings
3.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
520
Price
$323.59
Total Value
$168.26K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,560
Price
$322.71
Total Value
$503.42K
Shares Held After
520
% of Holdings
75.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,109
Price
$321.61
Total Value
$4.22M
Shares Held After
2,080
% of Holdings
86.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,505
Price
$321.00
Total Value
$6.58M
Shares Held After
15,189
% of Holdings
57.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,097
Price
$319.99
Total Value
$4.83M
Shares Held After
35,694
% of Holdings
29.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,402
Price
$318.55
Total Value
$2.04M
Shares Held After
50,791
% of Holdings
11.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
42,798
Price
$317.79
Total Value
$13.60M
Shares Held After
57,193
% of Holdings
42.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
32,224
Price
$316.82
Total Value
$10.21M
Shares Held After
99,991
% of Holdings
24.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
19,752
Price
$316.00
Total Value
$6.24M
Shares Held After
132,215
% of Holdings
13.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
9,516
Price
$314.73
Total Value
$2.99M
Shares Held After
151,967
% of Holdings
5.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4,881
Price
$314.08
Total Value
$1.53M
Shares Held After
161,483
% of Holdings
2.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
233
Price
$311.98
Total Value
$72.69K
Shares Held After
166,364
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
11
Price
$537.11
Total Value
$5.91K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
150
Price
$536.29
Total Value
$80.44K
Shares Held After
324,454
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$535.20
Total Value
$385.34K
Shares Held After
324,604
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,198
Price
$534.31
Total Value
$640.10K
Shares Held After
325,324
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$533.28
Total Value
$234.64K
Shares Held After
326,522
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$532.14
Total Value
$276.71K
Shares Held After
326,962
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,924
Price
$530.14
Total Value
$1.02M
Shares Held After
327,482
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,057
Price
$529.46
Total Value
$1.62M
Shares Held After
329,406
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,400
Price
$528.42
Total Value
$739.78K
Shares Held After
332,463
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$527.31
Total Value
$42.19K
Shares Held After
333,863
% of Holdings
0.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
9,500
Price
$23.18
Total Value
$220.22K
Shares Held After
585,038
% of Holdings
1.6%
Greenland Mines Ltd (GRML)
LeBlanc Jeff — Chief Financial Officer
Shares
1,400,000
Price
$0.18
Total Value
$245.28K
Shares Held After
4,820,342
% of Holdings
29.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2
Price
$1.55
Total Value
$3.10
Shares Held After
75,019
% of Holdings
0.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
19
Price
$1.55
Total Value
$29.45
Shares Held After
743,057
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
18,491
Price
$2.44
Total Value
$45.12K
Shares Held After
2,854,072
% of Holdings
0.6%
Showing 851–900 of 3404 transactions (page 18 of 69)